In addition to elucidating a new role of CDK4 in the control of energy homeostasis, the effects of CDK4 depletion in BAT function justify to set up new studies based on the use CDK4 inhibitors for the treatment of metabolic diseases. This evidence concerns the gene CDK4 and metabolic disease.